Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Vomiting × Sugars × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 3 Neoplasms 2 Vomiting 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1 Pain 1 Nausea 1 Myasthenia Gravis 1 Memory Disorders 1 Leiomyoma 1 Hot Flashes 1 Fatigue 1 Cognitive Dysfunction 1 Cancer Pain 1 Anemia 1

Interventions

Dexamethasone 22 Ondansetron 12 Palonosetron 11 Aprepitant 9 Granisetron 7 Olanzapine 5 ramosetron 3 netupitant, palosentron drug combination 3 casopitant 3 Radiotherapy 3 fosaprepitant 2 Thalidomide 2 Prochlorperazine 2 Electroacupuncture 2 Dronabinol 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant 1 lerisetron 1 dolasetron 1 dexamethasone acetate 1 Tropisetron 1 Therapeutics 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated

43 enrolled 5 charts

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡